cPLA2 was discovered to regulate the reversible transition of cervical cancer stem cells between mesenchymal and epithelial states via the atypical protein kinase PKCζ, regulate cancer cell EMT state changes, and maintain various embryonic stem cells cell characteristics via the interaction between β-catenin and E-cadherin [77]. Here, CDH1 is linked to cancer.